Course and prognosis of myasthenia gravis: A systematic review

European Journal of Neurology

Volumn 17, Issue 7, 2010, Pages 913-921

  Mao, Z F ^a   Mo, X A ^a   Qin, C ^a   Lai, Y R ^a   Olde Hartman, T C ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

course; myasthenia; prognosis; systematic review

Indexed keywords

ADULT; DISEASE COURSE; DISEASE DURATION; EMBASE; FOLLOW UP; HUMAN; MEDICAL LITERATURE; MEDLINE; MULTIVARIATE ANALYSIS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REMISSION; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW;

AGE OF ONSET; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; MYASTHENIA GRAVIS; PROGNOSIS; REVIEW LITERATURE AS TOPIC; SEX DISTRIBUTION;

EID: 77953847739     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03017.x     Document Type: Review

References (39)

1. Phillips LH 2nd., Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996 47: 1233 1238.
2. Phillips LH 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci 2003 998: 407 412.
3. Owe JF, Daltveit AK, Gilhus NE. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. J Neurol Neurosurg Psychiatry 2006 77: 203 207.
4. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008 37: 141 149.
5. Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology 2003 61: 1652 1661.
6. Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 2003 998: 413 423.
7. Jaretzki A 3rd., Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000 55: 16 23.
8. Hudak PL, Cole DC, Frank JW. Perspectives on prognosis of soft tissue musculoskeletal disorders. Int J Rehabil Res 1998 21: 29 40.
9. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001 323: 224 228.
10. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006 144: 427 437.
11. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ 2006 332: 749 755.
12. Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009 29: 502 510.
13. Sackett DL, Straus SE, Richardson WS. How to Practice and Teach EBM.
14. Ariens GA, Van Mechelen W, Bongers PM, Bouter LM, Van der Wal G. Physical risk factors for neck pain. Scand J Work Environ Health 2000 26: 7 19.
15. Olde Hartman TC, Borghuis MS, Lucassen PL, Van de Laar FA, Speckens AE, Van Weel C. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res 2009 66: 363 377.
16. Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008 52: 262 271. (Pubitemid 351978133)
17. Al-Moallem MA, Alkali NH, Hakami MA, Zaidan RM. Myasthenia gravis: presentation and outcome in 104 patients managed in a single institution. Ann Saudi Med 2008 28: 341 345.
18. Beekman R, Kuks JB, Oosterhuis HJ. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 1997 244: 112 118.
19. Beghi E, Antozzi C, Batocchi AP, et al. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 1991 106: 213 220.
20. Chan KH, Cheung RT, Mak W, Ho SL. Nonthymoma early-onset-and late-onset-generalized myasthenia gravis-a retrospective hospital-based study. Clin Neurol Neurosurg 2007 109: 686 691.
21. Cosi V, Romani A, Lombardi M, et al. Prognosis of myasthenia gravis: a retrospective study of 380 patients. J Neurol 1997 244: 548 555.
22. Donaldson DH, Ansher M, Horan S, Rutherford RB, Ringel SP. The relationship of age to outcome in myasthenia gravis. Neurology 1990 40: 786 790.
23. Hayashi M, Kida K, Sonoda S, Inoue H, Matsuda H. Factors influencing the clinical type and course of myasthenia gravis. Brain Dev 1992 14: 88 93.
24. Kapinas K, Kimiskidis VK, Kazis AD, Kokkas B, Tsolaki M, Georgiadis G. Myasthenia gravis: correlation of age with clinical course and anti-AChr antibody levels. Int J Immunopathol Pharmacol 1999 12: 127 131.
25. Mantegazza R, Beghi E, Pareyson D, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990 237: 339 344.
26. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989 52: 1121 1127.
27. Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 2005 12: 413 418.
28. Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 2007 78: 1109 1112.
29. Chmura Kraemer H, Periyakoil VS, Noda A. Kappa coefficients in medical research. Stat Med 2002 21: 2109 2129.
30. Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol 1991 48: 733 739.
31. Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia gravis in individuals over 40. Ann N Y Acad Sci 2003 998: 424 431.
32. Aarli JA. Late-onset myasthenia gravis: a changing scene. Arch Neurol 1999 56: 25 27.
33. Newsom-Davis J, Cutter G, Wolfe GI, et al. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. Ann N Y Acad Sci 2008 1132: 344 347.
34. Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess. 2007 11: iii, ix-51.
35. Khuraibet AJ, Rousseff RT, Behbehani R, al-Shubaili AF, Khan RA. Single-fiber electromyography of masseter muscle in myasthenia gravis. Muscle Nerve 2008 37: 522 525.
36. Mullins LL, Carpentier MY, Paul RH, Sanders DB. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 2008 38: 947 956.
37. Knieling J, Weiss H, Faller H, Lang H, Schalke B, Toyka K. [Follow-up of myasthenia gravis. Results of a longitudinal study of the significance of psychosocial predictors]. Nervenarzt. 1998 69: 137 144.
38. Hong YH, Kwon SB, Kim BJ, et al. Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients. J Neurol Sci 2008 273: 10 14.
39. Suzuki S, Utsugisawa K, Nagane Y, et al. Classification of myasthenia gravis based on autoantibody status. Arch Neurol 2007 64: 1121 1124.